The Current Ratio as of November 2024 (TTM) for Unicycive Therapeutics, Inc. (UNCY) is 3.61

According to Unicycive Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.61. This represents a change of 52.81% compared to the average of 2.36 of the last 4 quarters.

Unicycive Therapeutics, Inc. (UNCY) Historical Current Ratio (quarterly & annually)

How has UNCY Current Ratio performed in the past?

The mean historical Current Ratio of Unicycive Therapeutics, Inc. over the last ten years is 1.74. The current 3.61 Current Ratio has changed 20.66% with respect to the historical average. Over the past ten years (40 quarters), UNCY's Current Ratio was at its highest in in the September 2021 quarter at 25.20. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Unicycive Therapeutics, Inc. (UNCY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Unicycive Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Unicycive Therapeutics, Inc. (UNCY) Average Current Ratio

How has UNCY Current Ratio performed in the past?

The current Current Ratio of Unicycive Therapeutics, Inc. (UNCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Unicycive Therapeutics, Inc. (UNCY) Current Ratio vs. Peers

How is UNCY’s Current Ratio compared to its peers?

Unicycive Therapeutics, Inc.’s Current Ratio is greater than TransCode Therapeutics, Inc. (1.58), less than Ambrx Biopharma Inc. (12.80), less than Cardio Diagnostics Holdings, Inc. (8.51), greater than Hillstream BioPharma, Inc. (2.25), greater than SeqLL Inc. (0.91),

Build a custom stock screener for Unicycive Therapeutics, Inc. (UNCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unicycive Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unicycive Therapeutics, Inc. (UNCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unicycive Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.